Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/ISRG/Filing changes

ISRG — what changed in the latest 10-Q

A section-by-section comparison of ISRG's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.

Comparing 10-Q · 2026-10-21 vs the prior 10-Q · 2026-07-21

SectionOutcomeAddedRemovedMinorUnchanged
MD&AText added/removed+51−37~5884
Market risk (Item 3)Text added/removed00~10
Controls & proceduresText added/removed00~12
Legal proceedingsNo paragraph-level changes0001
Risk factorsNo paragraph-level changes0004
Other informationText added/removed0−4~10

Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.

Representative excerpts

Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.

MD&A

Text added vs the prior filing · source: 10-Q · 2026-10-21

  • does not receive preliminary or final court approval on the agreed terms or at all, including as a result of objections by class members, or that any approval is appealed; adverse publicity regarding us and the safety of our products and adequacy of training; the offering of remanufactured or unauth…
  • Additionally, we extended our fourth-generation platform by adding the da Vinci SP surgical system, commercialized in 2018. The da Vinci SP surgical system accesses the body through a single incision, while the other da Vinci surgical systems access the body through multiple incisions. We are in the…
  • Following the Supreme Court’s ruling, the U.S. imposed a temporary 10% import surcharge under Section 122 of the Trade Act of 1974. The Section 122 surcharge applied to most imports entered for consumption, or withdrawn from warehouse for consumption, from February 24, 2026 through July 24, 2026, su…
  • Effective July 24, 2026, following the expiration of the temporary Section 122 surcharge, the U.S. imposed additional duties under Section 301 of the Trade Act of 1974 on products from 60 trading partners in connection with determinations by the Office of the U.S. Trade Representative concerning the…
  • As a result of the Supreme Court’s ruling in February 2026, and in response to the order from the U.S. Court of International Trade, the U.S. Customs and Border Protection (“CBP”) agency formalized a process for refunds. On April 20, 2026, the CBP launched an online portal to submit IEEPA tariff ref…

Text removed vs the prior filing · source: 10-Q · 2026-07-21

  • expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors described throughout this filing and identified under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, as updated by our…
  • (the “EU MDR”) for the da Vinci 5 surgical system for adult and pediatric use in minimally invasive endoscopic procedures across abdominopelvic and thoracoscopic surgical procedures, including urologic, gynecologic, and general laparoscopic procedures, excluding the use of force feedback. We are cur…
  • Additionally, we extended our fourth-generation platform by adding the da Vinci SP surgical system, commercialized in 2018. The da Vinci SP surgical system accesses the body through a single incision, while the other da Vinci surgical systems access the body through multiple incisions. We are in the…
  • President to impose tariffs. In response to the Supreme Court’s ruling, a new 10% tariff for all imports under Section 122 of the Trade Act of 1974 was imposed. These tariffs took effect on February 24, 2026, and will remain in effect for 150 days, the maximum period that Section 122 permits without…
  • As a result of the Supreme Court’s ruling, and in response to the order from the U.S. Court of International Trade, the U.S. Customs and Border Protection (“CBP”) agency formalized a process for refunds. On April 20, 2026, the CBP launched an online portal to submit IEEPA tariff refund requests. All…

Other information

Text removed vs the prior filing · source: 10-Q · 2026-07-21

  • On May 10, 2026, Amy L. Ladd, M.D., a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading plan. Dr. Ladd’s trading plan provides for the potential sale of up to 472 shares of the Company’s common stock until May 15, 2027. This trading plan was entered into during an open inside…
  • On May 27, 2026, Patricia L. Wadors, the Company’s Chief Human Resources Officer, adopted a Rule 10b5-1 trading plan. Ms. Wadors’ trading plan provides for the potential sale of up to 3,494 shares of the Company’s common stock until May 29, 2027. This trading plan was entered into during an open ins…
  • On June 7, 2026, Henry L. Charlton, the Company’s former EVP & Chief Commercial and Marketing Officer, adopted a Rule 10b5-1 trading plan. Mr. Charlton’s trading plan provides for the potential sale of up to 26,124 shares of the Company’s common stock, including the potential exercise and sale of up…
  • On June 8, 2026, Fredrik C. Widman, the Company’s Vice President, Corporate Controller, adopted a Rule 10b5-1 trading plan. Mr. Widman’s trading plan provides for the potential sale of up to 19,026 shares of the Company’s common stock, including the potential exercise and sale of up to 16,346 shares…

How to read Risk Factors (Item 1A) in a 10-Q

A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:

  • Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
  • Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
  • Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.

This describes the filing structure only — it is never a judgement on whether risk went up or down.

Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice

More on ISRG

ISRG overviewISRG quant ratingISRG fair value (DCF)ISRG vs peersISRG revenue historyISRG AI deep research

Filing changes for similar stocks

SYK filing changesMDT filing changesBSX filing changes